Differential modulation of the tyrosine phosphorylation state of the insulin receptor by IRS (Insulin Receptor Subunit) proteins

Molecular Endocrinology

Volumn 13, Issue 10, 1999, Pages 1784-1798

  Solow, Barbara T ^a   Harada, Shuko ^a   Goldstein, Barry J ^b   Smith, Judith A ^a   White, Morris F ^c   Jarett, Leonard ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c JOSLIN DIABETES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN RECEPTOR; PERVANADATE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE; RECEPTOR SUBUNIT;

ANIMAL CELL; ARTICLE; ENZYME ACTIVITY; ENZYME INHIBITION; HORMONAL REGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 0033304651     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.13.10.0361     Document Type: Article

References (64)

1. Insulin action and the insulin signaling network
2. Regulation of the insulin signaling pathway by cellular protein-tyrosine phosphatases
3. 2 and vanadate enhances insulin receptor mediated tyrosine phosphorylation of IRS-1 leading to IRS-1 association with the phosphatidylinositol 3-kinase
4. Transgenic mice deficient in the LAR protein-tyrosine phosphatase exhibit profound defects in glucose homeostasis
5. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene
6. The new elements in insulin signaling. Insulin receptor substrate-1 and proteins with SH2 domains
7. Aminoacid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus
8. Variant sequences of insulin receptor substrate-1 in patients with noninsulin-dependent diabetes mellitus
9. Insulin receptor substrate-1 gene mutations in NIDDM: Implications for the study of polygenic disease
10. A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. Evidence from transfection studies
11. Molecular scanning of the insulin receptor substrate-1 (IRS-1) gene in Japanese patients with NIDDM: Identification of five novel polymorphisms
12. Alternative pathway of insulin signaling in mice with targeted disruption of the IRS-1 gene
13. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1
14. The IRS-signaling system: A network of docking proteins that mediate insulin action
15. IRS-1: Essential for insulin- and IL-4-stimulated mitogenesis in hematopoietic cells
16. Insulin-induced egr-1 and c-fos expression in 32D cells requires insulin receptor, shc, and mitogen-activated protein kinase, but not insulin receptor substrate-1 and phosphatidylinositol 3-kinase activation
17. Distinct modes of interaction of SHC and insulin receptor substrate-1 with the insulin receptor NPEY region via non-SH2 domains
18. Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate 1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain
19. Functional importance of amino-terminal domain of Shc for interaction with insulin and epidermal growth factor receptors in phosphorylation-independent manner
20. YMXM motifs and signaling by an insulin receptor substrate I molecule without tyrosine phosphorylation sites
21. Insulin stimulates the tyrosine dephosphorylation of pp125 focal adhesion kinase
22. Insulin induces tyrosine phosphorylation of JAK2 in insulin-sensitive tissues of the intact rat
23. The Grb2-associated protooncogene product Cbl is tyrosine phosphorylated in response to insulin in 3T3-L1 adipocytes: A possible role in the formation of intermolecular signaling complexes
24. Role of the complex formation of SHIPS-1 with SHP-2 in insulin-stimulated mitogen-activated protein kinase activation
25. Role of binding proteins to IRS-1 in insulin signaling
26. Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate
27. Activation of mitogen-activated protein (MAP) kinase pathway by pervanadate, a potent inhibitor of tyrosine phosphatases
28. IRS-1 activates phosphatidylinositol 3'-kinase by associating with src homology 2 domains of p85
29. The phosphatidylinositol 3-kinase serine kinase phosphorylates IRS-1: Stimulation by insulin and inhibition by wortmannin
30. The pleckstrin homology domain is the principle link between the insulin receptor and IRS-1
31. Separate domains of the insulin receptor contain sites of autophosphorylation and tyrosine kinase activity
32. Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose
33. Characterization of the insulin receptor with an in vitro mutation at tyrosine 1146: Evidence for separate insulin receptor signals regulating cellular metabolism and growth
34. The role of insulin receptor kinase domain autophosphorylation in receptor-mediated activities
35. Insulin receptor kinase domain autophosphorylation regulates receptor enzymatic function
36. Insulin regulation of membrane-associated insulin receptor substrate 1
37. Functional association between the insulin receptor and the transmembrane protein-tyrosine phosphataes LAR in intact cells
38. Form and function in protein dephosphorylation
39. The role of phosphotyrosine phosphatases in hematopoietic cell signal transduction
40. Isolation and characterization of a tyrosyl phosphatase activator from rabbit skeletal muscle and Xenopus laevis oocytes
41. 2+/ phospholipid-dependent protein kinases
42. Activation of a phosphotyrosine phosphatase by tyrosine phosphorylation
43. A peptide-based protein-tyrosine phosphatase inhibitor specifically enhances insulin receptor function in intact cells
44. Insulin receptor signaling is augmented by antisense inhibition of the protein tyrosine phosphatase LAR
45. Modulation of insulin signal transduction by eutopic overexpression of the receptor-type protein-tyrosine phosphatase LAR
46. Osmotic loading of neutralizing antibodies demonstrates a role for protein-tyrosine phosphatase 1B in negative regulation of the insulin action pathway
47. Differential activities of protein tyrosine phosphatases in intact cells
48. The transmembrane protein tyrosine phosphatase α dephosphorylated the insulin receptor in intact cells
49. The transmembrane protein-tyrosine phosphatase CD45 is associated with decreased insulin receptor signaling
50. Dephosphorylation of insulin receptor substrate 1 by the tyrosine phosphatase PTP2C
51. Src homology-2 domains of protein tyrosine phosphatases are phosphorylated by insulin receptor kinase and bind to the COOH-terminus of insulin receptors in vitro
52. Src homology 2 domains of protein tyrosine phosphatase are associated in vitro with both the insulin receptor and insulin receptor substrate-1 via different phosphotyrosine motifs
53. Activation of a phosphotyrosine phosphatase by tyrosine phosphorylation
54. Expression of catalytically inactive Syp phosphatase in 3T3 cells blocks stimulation of mitogen-activated protein kinase by insulin
55. Protein-tyrosine-phosphatase SHPTP2 is a required positive effector for insulin downstream signalling
56. Tyrosine phosphorylation of insulin receptor substrate-1 in vivo depends upon the presence of its pleckstrin homology region
57. Characterization of an interaction between insulin receptor substrate 1 and the insulin receptor by using the two-hybrid system
58. Recombinant human insulin receptor substrate-1 protein
59. Insulin receptor substrate-2 binds to the insulin receptor through its phosphotyrosine-binding domain and through a newly identified domain comprising amino acids 591-786
60. 628 in insulin receptor substrate-2 mediate its association with the insulin receptor
61. Stimulation of protein synthesis, eukaryotic translation initiation factor 4E phosphorylation, and PHAS-I phosphorylation by insulin requires insulin receptor substrate 1 and phosphatidylinositol 3-kinase
62. Purification of protein-tyrosine phosphatases from human placenta
63. The insulin receptor tyrosine kinase
64. Partial characterization of mechanisms of insulin accumulation in H35 hepatoma cell nuclei